Brief: Avrobio Reports Fourth Quarter And Fiscal Year 2022 Financial Results
March 23 (Reuters) - Avrobio Inc AVRO.O :
* AVROBIO REPORTS FOURTH QUARTER AND FISCAL YEAR 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* QTRLY NET LOSS PER SHARE - BASIC AND DILUTED $0.57
* QTRLY AVROBIO REPORTED A NET LOSS OF $25.0 MILLION FOR Q4
OF
2022
* Q4 EARNINGS PER SHARE VIEW $-0.49 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw3hH69ka
Further company coverage: AVRO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tectonic Therapeutic
See all newsTectonic Therapeutic Inc reports results for the quarter ended June 30 - Earnings Summary
Tectonic Therapeutic Q2 net loss widens on higher costs
Tectonic Therapeutic Inc expected to post a loss of $1.35 a share - Earnings Preview
Brief: Tectonic Therapeutic Completes Enrollment In Tx45 Apex Phase 2 Clinical Trial In Ph-Hfpef Patients
Tectonic Therapeutic Q1 net loss widens on higher R&D costs